-
Ready-to-use recombinant VSV vectors, (courtesy: AMSBIO)
Laboratory products
Virus-based Tools for Cell Engineering
Oct 28 2022
AMSBIO has added a new range of Vesicular Stomatitis Virus (VSV) to its suite of virus-based tools for cell engineering and the study of viral infection.
Vesicular Stomatitis Virus is an enveloped, negative-stranded RNA virus with a simple structure. Its ability to infect a wide range of mammalian cell types has made it a valuable tool to study virus entry, replication, and assembly. A key advantage of the AMSBIO VSV model is that it undergoes only one round of replication. Consequently, it is safe to use and requires only a biosafety level 2 facility.
VSV vectors offer a robust model of viral infection that can be efficiently pseudo typed with envelope glycoproteins derived from heterologous viruses, making them highly suitable for studying the entry mechanisms of such high-risk viruses.
Drawing upon proprietary technologies and reagents, recombinant VSV vectors from AMSBIO benefit from top quality production protocols that deliver products unmatched in terms in terms of titer, purity, viability and consistency.
Recombinant VSV vectors from AMSBIO are the viral product of choice for a growing variety of applications including studying mechanisms of viral entry into host cells, identification of cellular receptors used by viruses for cell entry, screening of viral entry inhibitors and vaccine development research.
More information online
Digital Edition
Lab Asia Dec 2025
December 2025
Chromatography Articles- Cutting-edge sample preparation tools help laboratories to stay ahead of the curveMass Spectrometry & Spectroscopy Articles- Unlocking the complexity of metabolomics: Pushi...
View all digital editions
Events
Jan 21 2026 Tokyo, Japan
Jan 28 2026 Tokyo, Japan
Jan 29 2026 New Delhi, India
Feb 07 2026 Boston, MA, USA
Asia Pharma Expo/Asia Lab Expo
Feb 12 2026 Dhaka, Bangladesh



